Human oxLDL Antibody (Okayama U. patent anti-oxLDL, Research Use)

产品名称	Human oxLDL Antibody (Okayama U. patent anti-oxLDL, Research Use)
目录号	NBR-0761
别名	CLEC8A; LOX-1; SCARE1
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0761-100UG	100ug	￥550	请咨询
NBR-0761-1MG	1mg	￥3500	请咨询
NBR-0761-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human oxLDL Antibody (Okayama U. patent anti-oxLDL, Research Use)
产品编号：NBR-0761
针对靶点：oxLDL
抗体药商品名：Okayama U. patent anti-oxLDL
抗体药描述：The drug is a recombinant fully human anti-oxLDL monoclonal antibody, being developed by Okayama U.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: OLR1
Synonyms: CLEC8A; LOX-1; SCARE1
Target Description: Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis.
Ensembl: ENSG00000173391
Uniprot: P78380